Home
›
Books
›
ASCO 2026: Lung Cancer Treatment Options, New Studies - Cancer Therapy Advisor
ASCO 2026: Lung Cancer Treatment Options, New Studies - Cancer Therapy Advisor
By Bryant Furlow
Chapters
Introduction
1 concept
ASCO 2026: Studies Aim to Expand Treatment Options for Lung Cancer
0 concepts
— CHRYSALIS-2: First-Line Amivantamab Plus Lazertinib
4 concepts
— CROWN: 7-Year Update for Lorlatinib
4 concepts
— ROSETTA Lung-02: Pumitamig
4 concepts
— TRITON: Tremelimumab Plus Durvalumab and Chemotherapy
3 concepts
ASCO 2026: Lung Cancer Treatment Options, New Studies - Cancer Therapy Advisor | Bryant Furlow | Bifalgorithm | Bifalgorithm